ADAG Adagene Inc

Price (delayed)

$3.675

Market cap

$246.75M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.38

Enterprise value

$124.93M

?
Relative Growth: Rel. Growth: 35
Relative Strength: Rel. Strength: 87
Relative Valuation: Rel. Valuation: 7
Relative Profitability: Rel. Profitability: 37

Adagene Inc. is a platform-driven, clinical-stage biopharmaceutical company committed to transforming the discovery and development of novel antibody-based cancer immunotherapies. Adagene combines computational biology and artificial intelligence to design novel ...

Highlights
ADAG's equity has surged by 136% year-on-year
The quick ratio has soared by 121% year-on-year

Key stats

What are the main financial stats of ADAG

ADAG stock price

How has the Adagene stock price performed over time
Intraday
-0.41%
1 week
-5.77%
1 month
1.24%
1 year
68.58%
YTD
94.44%
QTD
-12.5%

Financial performance

How have Adagene's revenue and profit performed over time
Revenue
$9.29M
Gross profit
$9.29M
Operating income
-$22.03M
Net income
-$20.51M
Gross margin
100%
Net margin
-220.8%
The net margin has surged by 99% year-on-year
The operating margin has soared by 99% YoY
ADAG's operating income is up by 33% year-on-year
ADAG's net income is up by 31% year-on-year

Price vs fundamentals

How does ADAG's price correlate with its fundamentals

Growth

What is Adagene's growth rate over time

Valuation

What is Adagene stock price valuation
P/E
N/A
P/B
1.95
P/S
22.4
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
13.45
ADAG's EPS is up by 41% year-on-year
ADAG's equity has surged by 136% year-on-year

Efficiency

How efficient is Adagene business performance
ADAG's return on sales has surged by 99% year-on-year
The ROE has grown by 49% YoY
The ROA rose by 43% YoY

Dividends

What is ADAG's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ADAG.

Financial health

How did Adagene financials performed over time
The quick ratio has soared by 121% year-on-year
The company's current ratio has surged by 119% YoY
The debt is 93% smaller than the equity
ADAG's equity has surged by 136% year-on-year
Adagene's debt to equity has plunged by 61% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.